GTC Biotherapeutics (fka GTCB)

[keitern]

This quote is representative of what I perceive to be a high degree of confidence that GTCB engineers have in their platform. I translate this and other signals along these lines in terms of lower risk. It is a wonderful position for a company to be in when they have the luxury of controlling pricing through low cost production. GTCB is after very expensive, proven drugs that have existing markets and marketing in place but that are too expensive for widespread use. If GTCB can save more lives by making these expensive drugs more accessible, then this is more than just another bio tech looking for a wonder drug.